CRGX CARGO Therapeutics Inc
57
$20.42
$0.92
(4.31%)
| Watchers | 57 |
| 52-Wk Low | $13.14 |
| 52-Wk High | $33.92 |
| Market Cap | $804.06M |
| Volume | 154,175.00 |
| 52-Wk High | $33.92 |
| 52-Wk Low | $13.14 |
Contrasting CARGO Therapeutics (NASDAQ:CRGX) and Fate Therapeutics (NASDAQ:FATE)Ticker Report • about 1 month ago
Fate Therapeutics (NASDAQ:FATE - Get Free Report) and CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two...
Share to Feed
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CRGX stock results show that Cargo Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
The post...
Potentially pivotal Phase 2 clinical study FIRCE-1 of firicabtagene autoleucel (CRG-022) is rapidly recruiting with 20 sites open to date; interim results expected 1H 2025 SAN MATEO, Calif...
In recent trading, shares of CARGO Therapeutics Inc (CRGX) have crossed above the average analyst 12-month target price of 30.67, changing hands for 32.23/share. When a stock reaches the...
SAN MATEO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
SAN MATEO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...